21.2 C
New York
Thursday, June 18, 2026

Tag: failures

newssourceFORcompanyinformationcontent1marketreleases

NCS Multistage Holdings, Inc. Announces Second Quarter 2025 Results

Second Quarter Results

KLA CORPORATION REPORTS FISCAL 2025 FOURTH QUARTER AND FULL YEAR RESULTS

For the quarter, total revenues were $3.175 billion, towards the upper end of the guidance range;GAAP diluted EPS was $9.06, at the upper end...

Alpine Banks of Colorado announces financial results for second quarter 2025

GLENWOOD SPRINGS, Colo., July 31, 2025 (GLOBE NEWSWIRE) -- Alpine Banks of Colorado (OTCQX: ALPIB) (“Alpine” or the “Company”), the holding company for Alpine Bank (the “Bank”), today announced results (unaudited) for the second quarter ended June 30, 2025. The Company reported net income of $17.6 million, or $1.10 per basic Class A common share and basic Class B common share, for second quarter 2025.

InterDigital Announces Financial Results for Second Quarter 2025

Samsung arbitration decision and new HP license agreement drive Q2 results, exceeding outlook
Annualized recurring revenue1, at all-time high of $553 million, up 44% YoY
Company raises full year 2025 revenue guidance by $110 million

Lightspeed Announces First Quarter 2026 Financial Results

Total revenue in the quarter of $304.9 million grew 15% year-over-year and exceeded outlook Gross margin improved to 42%, with gross profit increasing 19% year-over-year exceeding...

Osteosarcoma Market on the Rise in the 7MM During the Forecast Period (2025-2034) with Novel Therapeutics and Technological Innovations | DelveInsight

The dynamics of the osteosarcoma market are anticipated to change due to the extensive R&D activities, entry of novel potential therapies such as HALMB-0168...

Osteosarcoma Market on the Rise in the 7MM During the Forecast Period (2025-2034) with Novel Therapeutics and Technological Innovations | DelveInsight

The dynamics of the osteosarcoma market are anticipated to change due to the extensive R&D activities, entry of novel potential therapies such as HALMB-0168...

Pilgrim’s Pride Reports Second Quarter 2025 Results with $4.8 Billion in Net Sales, Operating Income of $512.3 Million and Announces Special Dividend of Approximately...

GREELEY, Colo., July 30, 2025 (GLOBE NEWSWIRE) -- Pilgrim’s Pride Corporation (NASDAQ: PPC), one of the world's leading food companies, reports its second quarter 2025 financial results.

eBay Inc. Reports Second Quarter 2025 Results

Revenue of $2.7 billion, up 6% on an as-reported basis and up 4% on an FX-Neutral basisGross Merchandise Volume ("GMV") of $19.5 billion, up...

Schmicko Roof Lining Repair Launches New Birrong Location to Tackle Sagging Roof Linings in Sydney

Sydney, NSW, July 30, 2025 (GLOBE NEWSWIRE) -- Schmicko Roof Lining Repair has officially launched a new base of operations in Birrong, delivering expert car roof lining repairs to drivers in Bankstown, Parramatta, and surrounding Western Sydney suburbs. This expansion addresses a growing demand from locals facing sagging, bubbling, and drooping roof linings caused by Australia’s tough climate. 

Madrigal Pharmaceuticals Enters into Exclusive Global License Agreement for Oral GLP-1 Receptor Agonist with CSPC Pharmaceutical Group Limited

CONSHOHOCKEN, Pa., July 30, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) (“Madrigal”) today announced that it has entered into an exclusive global license agreement with CSPC Pharmaceutical Group Limited (HKEX Stock CodeL 1093) (“CSPC”) for SYH2086, a preclinical oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist and orforglipron derivative. Madrigal plans to initiate clinical development in the first half of 2026.

Triple-Negative Breast Cancer Market Gearing Up for Impressive Growth at a CAGR of 4.7% During the Forecast Period (2025-2034) | DelveInsight

The triple-negative breast cancer market is expected to grow due to rising incidence rates, increasing awareness, advancements in targeted therapies, ongoing clinical trials, improved...

Triple-Negative Breast Cancer Market Gearing Up for Impressive Growth at a CAGR of 4.7% During the Forecast Period (2025-2034) | DelveInsight

The triple-negative breast cancer market is expected to grow due to rising incidence rates, increasing awareness, advancements in targeted therapies, ongoing clinical trials, improved...

TOROMONT ANNOUNCES RESULTS FOR THE SECOND QUARTER OF 2025 AND QUARTERLY DIVIDEND

TORONTO, July 29, 2025 /CNW/ - Toromont Industries Ltd. (TSX: TIH) today reported its financial results for the second quarter ended June 30, 2025. Three...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsFailures

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers